Baldwin Brothers LLC MA increased its position in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) by 7.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 143,800 shares of the company’s stock after acquiring an additional 10,500 shares […]